Dolutegravir plus lamivudine downregulates cellular stress responses vs. three-drug HIV regimens.

IF 3.1 2区 医学 Q3 IMMUNOLOGY
AIDS Pub Date : 2025-07-15 Epub Date: 2025-04-01 DOI:10.1097/QAD.0000000000004198
Victoria Rios-Vazquez, Wilhelm A J W Vos, Marc J T Blaauw, Louise E Van Eekeren, Albert L Groenendijk, Adriana Navas, Nadira Vadaq, Leo A B Joosten, Mihai G Netea, Willem L Blok, Janneke E Stalenhoef, Lambert Van Den Heuvel, Andre J A M Van Der Ven, Jan Van Lunzen
{"title":"Dolutegravir plus lamivudine downregulates cellular stress responses vs. three-drug HIV regimens.","authors":"Victoria Rios-Vazquez, Wilhelm A J W Vos, Marc J T Blaauw, Louise E Van Eekeren, Albert L Groenendijk, Adriana Navas, Nadira Vadaq, Leo A B Joosten, Mihai G Netea, Willem L Blok, Janneke E Stalenhoef, Lambert Van Den Heuvel, Andre J A M Van Der Ven, Jan Van Lunzen","doi":"10.1097/QAD.0000000000004198","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To compare the systemic and immune effects of two-drug regimens (2DR) and three-drug regimens (3DR) in people with HIV (PWH).</p><p><strong>Design: </strong>In a cross-sectional study, multiomics data were analyzed in dolutegravir (DTG) plus lamivudine (3TC) 2DR and 3DR comprising DTG with two nucleoside reverse transcriptase inhibitors (NRTIs).</p><p><strong>Methods: </strong>Data from the 2000HIV cohort of virally suppressed PWH on combination antiretroviral treatment (cART) regimens were analyzed. Groups included DTG + 3TC ( n  = 191), DTG + 3TC + abacavir (ABC) ( n  = 188), and DTG + tenofovir disoproxil fumarate or tenofovir alafenamide (TDF/TAF) + emtricitabine (FTC) ( n  = 115). Systemic functions were assessed via plasma protein profiling (Olink Explore, 2367 proteins), while peripheral blood mononuclear cells (PBMCs) were used to evaluate immune effects by analyzing Bulk RNA-Seq and ex-vivo cytokine production capacity.</p><p><strong>Results: </strong>Plasma protein analysis revealed that 2DR associated to lower protein expression and pathways related to metabolism, stress responses, chemokine signaling, and immune responses compared to 3DR. Four proteins - CXCL8, DDC, PMM2, and EPS8L2 - were consistently downregulated in 2DR. Differential gene expression analysis identified 17 overlapping downregulated genes across all 3DR vs. 2DR comparisons, linked to chromatin structure, cellular senescence, stress response, and cytokine activity. Cytokine production was similar across 2DR and 3DR groups, except for enhanced interleukin (IL)-17 production in DTG + TDF + FTC users.</p><p><strong>Conclusions: </strong>Reducing NRTIs in DTG-based 2DR, particularly by omitting ABC or TAF/TDF, suggests decreased activation of stress response and immune-related pathways. Importantly, the functional capacity of circulating immune cells remains largely unchanged between 2DR and 3DR.</p>","PeriodicalId":7502,"journal":{"name":"AIDS","volume":" ","pages":"1106-1119"},"PeriodicalIF":3.1000,"publicationDate":"2025-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12237123/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"AIDS","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/QAD.0000000000004198","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/1 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To compare the systemic and immune effects of two-drug regimens (2DR) and three-drug regimens (3DR) in people with HIV (PWH).

Design: In a cross-sectional study, multiomics data were analyzed in dolutegravir (DTG) plus lamivudine (3TC) 2DR and 3DR comprising DTG with two nucleoside reverse transcriptase inhibitors (NRTIs).

Methods: Data from the 2000HIV cohort of virally suppressed PWH on combination antiretroviral treatment (cART) regimens were analyzed. Groups included DTG + 3TC ( n  = 191), DTG + 3TC + abacavir (ABC) ( n  = 188), and DTG + tenofovir disoproxil fumarate or tenofovir alafenamide (TDF/TAF) + emtricitabine (FTC) ( n  = 115). Systemic functions were assessed via plasma protein profiling (Olink Explore, 2367 proteins), while peripheral blood mononuclear cells (PBMCs) were used to evaluate immune effects by analyzing Bulk RNA-Seq and ex-vivo cytokine production capacity.

Results: Plasma protein analysis revealed that 2DR associated to lower protein expression and pathways related to metabolism, stress responses, chemokine signaling, and immune responses compared to 3DR. Four proteins - CXCL8, DDC, PMM2, and EPS8L2 - were consistently downregulated in 2DR. Differential gene expression analysis identified 17 overlapping downregulated genes across all 3DR vs. 2DR comparisons, linked to chromatin structure, cellular senescence, stress response, and cytokine activity. Cytokine production was similar across 2DR and 3DR groups, except for enhanced interleukin (IL)-17 production in DTG + TDF + FTC users.

Conclusions: Reducing NRTIs in DTG-based 2DR, particularly by omitting ABC or TAF/TDF, suggests decreased activation of stress response and immune-related pathways. Importantly, the functional capacity of circulating immune cells remains largely unchanged between 2DR and 3DR.

Dolutegravir +拉米夫定与三药HIV方案相比下调细胞应激反应。
目的:比较两药方案(2DR)和三药方案(3DR)对HIV感染者(PLHIV)的全身和免疫效果。设计:在一项横断研究中,多组学数据分析了多鲁特重力韦(DTG)加拉米夫定(3TC) 2DR和3DR,包括DTG和两种核苷逆转录酶抑制剂(NRTIs)。方法:对接受联合抗逆转录病毒治疗(cART)方案的2000例病毒抑制的PLHIV患者的数据进行分析。组包括DTG + 3TC (n = 191)、DTG + 3TC +阿巴卡韦(ABC) (n = 188)、DTG +富马酸替诺福韦二氧吡酯或替诺福韦α胺(TDF/TAF) +恩曲他滨(FTC) (n = 115)。通过血浆蛋白分析(Olink®Explore, 2367蛋白)评估全身功能,通过分析Bulk RNA-Seq和体外细胞因子生产能力,使用外周血单个核细胞(PBMCs)评估免疫效果。结果:血浆蛋白分析显示,与3DR相比,2DR与代谢、应激反应、趋化因子信号传导和免疫反应相关的蛋白表达和途径相关。四种蛋白cxcl8、DDC、PMM2和eps8l2在2DR中持续下调。差异基因表达分析在所有3DR和2DR比较中发现了17个重叠的下调基因,这些基因与染色质结构、细胞衰老、应激反应和细胞因子活性有关。除了DTG + TDF + FTC用户IL-17的产生增加外,2DR和3DR组的细胞因子产生相似。结论:在dtg为基础的2DR中减少nrti,特别是通过忽略ABC或TAF/TDF,表明应激反应和免疫相关途径的激活降低。重要的是,循环免疫细胞的功能能力在2DR和3DR之间基本保持不变。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
AIDS
AIDS 医学-病毒学
CiteScore
5.90
自引率
5.30%
发文量
478
审稿时长
3 months
期刊介绍: ​​​​​​​​​​​​​​​​​Publishing the very latest ground breaking research on HIV and AIDS. Read by all the top clinicians and researchers, AIDS has the highest impact of all AIDS-related journals. With 18 issues per year, AIDS guarantees the authoritative presentation of significant advances. The Editors, themselves noted international experts who know the demands of your work, are committed to making AIDS the most distinguished and innovative journal in the field. Submitted articles undergo a preliminary review by the editor. Some articles may be returned to authors without further consideration. Those being considered for publication will undergo further assessment and peer-review by the editors and those invited to do so from a reviewer pool.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信